This website is intended for healthcare professionals only.

Hospital Pharmacy Europe     Newsletter          

Oncology

Cone beam breast CT superior to MRI for detection of preoperative residual tumour
Cone beam breast CT superior to MRI for detection of preoperative residual tumour
Read more
Talquetamab effective in relapsed/refractory multiple myeloma
Talquetamab effective in relapsed/refractory multiple myeloma
Read more
Anti-CD20 therapy increases complication risk in COVID-19 for blood cancer patients
Anti-CD20 therapy increases complication risk in COVID-19 for blood cancer patients
Read more
CHMP recommends Enhertu for HER2-low breast cancer treatment
CHMP recommends Enhertu for HER2-low breast cancer treatment
Read more
Elranatamab induces durable clinical response in relapsed multiple myeloma
Elranatamab induces durable clinical response in relapsed multiple myeloma
Read more
mRNA-4157/V940 vaccine effective in advanced melanoma
mRNA-4157/V940 vaccine effective in advanced melanoma
Read more
Zanubrutinib improves progression-free survival in relapsed lymphocytic leukaemia
Zanubrutinib improves progression-free survival in relapsed lymphocytic leukaemia
Read more
Medical marijuana reduces opiate use among cancer patients
Medical marijuana reduces opiate use among cancer patients
Read more
Higher level of advanced colorectal cancer diagnosed during COVID-19
Higher level of advanced colorectal cancer diagnosed during COVID-19
Read more
Tisagenlecleucel effectiveness in paediatric leukaemia persists beyond 3 years
Tisagenlecleucel effectiveness in paediatric leukaemia persists beyond 3 years
Read more
Long-term radiotherapy reduces local breast cancer recurrence but not overall survival
Long-term radiotherapy reduces local breast cancer recurrence but not overall survival
Read more
Trastuzumab deruxtecan treatment of advanced gastric cancer recommended for EU approval 
Trastuzumab deruxtecan treatment of advanced gastric cancer recommended for EU approval 
Read more
Pembrolizumab with radiotherapy equal to cetuximab for advanced head and neck SCC
Pembrolizumab with radiotherapy equal to cetuximab for advanced head and neck SCC
Read more
Digital tumour infiltrating lymphocyte scoring predicts ICI benefit in lung cancer
Digital tumour infiltrating lymphocyte scoring predicts ICI benefit in lung cancer
Read more
Prostate cancer screening with MRI after PSA a cost-effective strategy
Prostate cancer screening with MRI after PSA a cost-effective strategy
Read more

Popular articles

Government commits to easing pressure on NHS through commercial clinical trial investment
Biobank pilot to be launched by MHRA to better understand genetics and medicines safety
Understanding the intricacies of tube feeding with Stephen Taylor





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora